Brazil’s IVD sector invited to table industry evidence for patient safety project
This article was originally published in Clinica
Executive Summary
Brazil’s in vitro diagnostic and laboratory supplies industry association, CBDL, has called on its members to help it collate feedback for a prospective government consultation on improving safety and service quality. CBDL has asked its members to submit feedback on three questions posed by healthcare products regulatory agency Anvisa: how can the CBDL contribute to the introduction of a national healthcare safety project; does such a project pose any risk or “negative impacts”; and are there any patient safety initiatives already in place? The CBDL is to participate in parliamentary discussions on the matter and is being invited to table details of specific patient safety initiatives already under way.